Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease - Results from the NHLBI Family Heart Study

被引:35
作者
Hopkins, PN
Hunt, SC
Schreiner, PJ
Eckfeldt, JH
Borecki, IB
Ellison, CR
Williams, RR
Siegmund, KD
机构
[1] Univ Utah, Sch Med, Dept Internal Med, Div Cardiol, Salt Lake City, UT 84132 USA
[2] Univ Minnesota, Div Epidemiol, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[4] Washington Univ, Div Biostat, St Louis, MO USA
[5] Univ Hosp, Sect Prevent Med & Epidemiol, Boston, MA USA
关键词
lipoprotein(a); plasma cholesterol; coronary heart disease; risk factors; case-control studies; genetics;
D O I
10.1016/S0021-9150(98)00174-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: A positive interaction between high plasma lipoprotein(a) [Lp(a)] and unfavorable plasma lipid levels has been reported to result in very high risk for premature coronary artery disease (CAD). We further examined this issue for men and women with early onset CAD. We also examined potential interactions between Lp(a) and non-lipid risk factors. Methods and results: In 338 men and women with early onset CAD (most with a positive family history of early CAD) and 480 general population controls, we measured Lp(a), lipids and other risk factors. In univariate analysis, relative odds for CAD was 1.7 (P = 0.002) for plasma Lp(a) > 50 mg/dl. Elevated Lp(a) level was found to interact with adjusted plasma total/high density lipoprotein (HDL) cholesterol such that when Lp(a) was over 50 mg/dl and adjusted plasma total/HDL cholesterol > 5.8, relative odds for CAD were 8.0-9.6 (P < 0.0001) in multiple logistic regression. Non-lipid risk factors were generally found to multiply the risk associated with Lp(a) (as predicted by logistic regression) without evidence for interaction. Conclusions: We find evidence that Lp(a) does interact positively with adjusted plasma total/HDL cholesterol ratio. Aggressive risk factor intervention, especially for lipids, in those with elevated Lp(a) therefore appears indicated. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:333 / 345
页数:13
相关论文
共 100 条
[1]   RELATION OF SERUM HOMOCYSTEINE AND LIPOPROTEIN(A) CONCENTRATIONS TO ATHEROSCLEROTIC DISEASE IN A PROSPECTIVE FINNISH POPULATION-BASED STUDY [J].
ALFTHAN, G ;
PEKKANEN, J ;
JAUHIAINEN, M ;
PITKANIEMI, J ;
KARVONEN, M ;
TUOMILEHTO, J ;
SALONEN, JT ;
EHNHOLM, C .
ATHEROSCLEROSIS, 1994, 106 (01) :9-19
[2]   The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor [J].
Argraves, KM ;
Kozarsky, KF ;
Fallon, JT ;
Harpel, PC ;
Strickland, DK .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) :2170-2181
[3]   THE ASSOCIATION BETWEEN SERUM LP(A) CONCENTRATIONS AND ANGIOGRAPHICALLY ASSESSED CORONARY ATHEROSCLEROSIS - DEPENDENCE ON SERUM LDL LEVELS [J].
ARMSTRONG, VW ;
CREMER, P ;
EBERLE, E ;
MANKE, A ;
SCHULZE, F ;
WIELAND, H ;
KREUZER, H ;
SEIDEL, D .
ATHEROSCLEROSIS, 1986, 62 (03) :249-257
[4]   Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men [J].
Assmann, G ;
Schulte, H ;
vonEckardstein, A .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (14) :1179-1184
[5]   LIPOPROTEIN(A) AND ACCELERATED CORONARY-ARTERY DISEASE IN CARDIAC TRANSPLANT RECIPIENTS [J].
BARBIR, M ;
KUSHWAHA, S ;
HUNT, B ;
MACKEN, A ;
THOMPSON, GR ;
MITCHELL, A ;
ROBINSON, D ;
YACOUB, M .
LANCET, 1992, 340 (8834-5) :1500-1502
[6]  
Bartens W, 1996, PERITON DIALYSIS INT, V16, P27
[7]   Apolipoprotein(a) attenuates endogenous fibrinolysis in the rabbit jugular vein thrombosis model in vivo [J].
Biemond, BJ ;
Friederich, PW ;
Koschinsky, ML ;
Levi, M ;
Sangrar, W ;
Xia, JZ ;
Buller, HR ;
tenCate, JW .
CIRCULATION, 1997, 96 (05) :1612-1615
[8]   INTERACTION OF LIPOPROTEIN LP(A) AND LOW-DENSITY LIPOPROTEIN WITH GLYCOSAMINOGLYCANS FROM HUMAN AORTA [J].
BIHARIVARGA, M ;
GRUBER, E ;
ROTHENEDER, M ;
ZECHNER, R ;
KOSTNER, GM .
ARTERIOSCLEROSIS, 1988, 8 (06) :851-857
[9]   DOSE-RESPONSE RELATIONSHIPS OF SERUM-LIPID MEASUREMENTS WITH THE EXTENT OF CORONARY STENOSIS - STRONG, INDEPENDENT, AND COMPREHENSIVE [J].
BOLIBAR, I ;
THOMPSON, SG ;
VONECKARDSTEIN, A ;
SANDKAMP, M ;
ASSMANN, G .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (08) :1035-1042
[10]   Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger - A prospective study [J].
Bostom, AG ;
Cupples, LA ;
Jenner, JL ;
Ordovas, JM ;
Seman, LJ ;
Wilson, PWF ;
Schaefer, EJ ;
Castelli, WP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (07) :544-548